Peer Group

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Drug Manufacturers—General Average - - - - - - 175,085.50 8,838.56 353.83 22,710.06 892.71 0.57 4.2506 0.21 63.9339 2.6376 0.26 -0.10 90.2971 - -
Maximum - - - - - - 860,107.00 21,382.00 4,762.00 153,378.00 3,847.00 1.51 76.3636 2.71 82.5000 30.1200 4.50 17.51 350.2200 - -
Minimum - - - - - - 0.00 944.00 -11,911.00 -27,870.00 -1,932.00 0.00 -335.6404 -5.89 6.4100 -100.3900 -12.03 -72.23 0.0000 - -
AstraZeneca PLC AZNCF 157.80 0.00 0.00% 0 vs. 1 244,635.00 12,622.00 2,179.00 - - - - 1.4000 - - - - 75.21 - - - - - - - - 1,550.00
Bayer Aktiengesellschaft BAYRY 7.78 0.15 1.97% 54 vs. 890 30,573.00 13,765.00 2,000.00 -2,626.00 0.00 2.0400 0.8741 0.00 60.31 14.53 5.62 1.67 87.22 3,929.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for AZNCF and its peers to uncover potential buy and sell opportunities.